期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Biodegradation of tetrabromobisphenol A in the sewage sludge process
1
作者 Xingxing Peng Zhangna Wang +2 位作者 Dongyang Wei qiyuan huang Xiaoshan Jia 《Journal of Environmental Sciences》 SCIE EI CAS CSCD 2017年第11期39-48,共10页
Anaerobic sewage sludge capable of rapidly degrading tetrabromobisphenol A(TBBPA) was successfully acclimated in an anaerobic reactor over 280 days. During the period from 0 to 280 days, the TBBPA degradation rate... Anaerobic sewage sludge capable of rapidly degrading tetrabromobisphenol A(TBBPA) was successfully acclimated in an anaerobic reactor over 280 days. During the period from 0 to 280 days, the TBBPA degradation rate(DR), utilization of glucose, and VSS were monitored continuously. After 280 days of acclimation, the TBBPA DR of active sludge reached 96.0% after 20 days of treatment in batch experiments. Based on scanning electron microscopy(SEM) observations and denaturing gradient gel electrophoresis(DGGE) determinations,the diversity of the microorganisms after 0 and 280 days in the acclimated anaerobic sewage sludge was compared. Furthermore, eleven metabolites, including 2-bromophenol,3-bromophenol, 2,4-dibromophenol, 2,6-dibromophenol, tribromophenol and bisphenol A,were identified by gas chromatography–mass spectrometry(GC–MS). Moreover, the six primary intermediary metabolites were also well-degraded by the acclimated anaerobic sewage sludge to varying degrees. Among the six target metabolites, tribromophenol was the most preferred substrate for biodegradation via debromination. These metabolites degraded more rapidly than monobromide and bisphenol A. The biodegradation data of the intermediary metabolites exhibited a good fit to a pseudo-first-order model.Finally, based on the metabolites, metabolic pathways were proposed. In conclusion, the acclimated microbial consortia degraded TBBPA and its metabolites well under anaerobic conditions. 展开更多
关键词 Tetrabromobisphenol A BIODEGRADATION METABOLITES Anaerobic sewage sludge PATHWAYS
原文传递
Circulating biomarkers in perioperative management of cancerpatients
2
作者 qiyuan huang Ruihao Zhou +3 位作者 Xuechao Hao Weiyi Zhangl Guo Chen Tao Zhu 《Precision Clinical Medicine》 2023年第3期121-134,共14页
Owing to the advances in surgical technology,most solid tumours can be controlled by surgical excision.The priority should be tumour control,while some routine perioperative management might influence cancer progressi... Owing to the advances in surgical technology,most solid tumours can be controlled by surgical excision.The priority should be tumour control,while some routine perioperative management might influence cancer progression in an unnoticed way.Moreover,it is increasingly recognized that effective perioperative management should include techniques to improve postoperative outcomes.These influences are elucidated by the different functions of circulating biomarkers in cancer patients.Here,circulating biomarkers with two types of clinical functions were reviewed:(i)circulating biomarkers for cancer progression monitoring,for instance,those related to cancer cell malignancy,tumour microenvironment formation,and early metastasis,and(i)circulating biomarkers with relevance to postoperative outcomes,including systemic inflammation,immunosuppression,cognitive dysfunction,and pain management.This review aimed to provide new perspectives for the perioperative management of patients with cancer and highlight the potential clinical translation value of circulating biomarkers in improving outcomes. 展开更多
关键词 circulating biomarker perioperative outcome precision oncology perioperative medication
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部